StemCyte Debuts New Website The nation's most accredited cord blood bank unveils its redesigned website, including the introduction of MaxCell™ and StandardCell™ brands
COVINA, Calif., July 21, 2014 /PRNewswire-iReach/ -- StemCyte, Inc. (www.stemcyte.com) is delighted to announce a newly designed company website. The site features a clean, contemporary look, new logo and branding, narrated and illustrated homepage graphics, and streamlined messaging that underscores the company's proprietary stem cell collection method and superior transplant experience. Now, visitors will more easily find the important facts that set StemCyte apart from all other cord blood banks, such as being one of the only private cord blood banks that is both FACT and AABB accredited. Flexible pricing options and long-term financing are additional new elements that potential customers will find appealing.
Furthermore, the website launch marks the introduction of StemCyte's MaxCell™ and StandardCell™ brands. The MaxCell™ processing method is a patented and proprietary process offered only by StemCyte™ that saves more of a baby's cord blood stem cells. The process removes only the plasma and recovers a higher number of stem cells, compared to other methods. The StandardCell™ processing method removes plasma and red blood cells. Regardless of whether a unit undergoes MaxCell™ or StandardCell™ processing, it is tested equally to ensure quality, sufficient cell count, and viability of the stem cells.
Two new sections worth noting - "Why Bank" and "Tissue" - are information-rich resources for anyone wanting to learn more about umbilical cord blood stem cells, including current medical uses and potentially treatable diseases, as well as the benefits of banking baby's cord tissue. StemCyte is currently the only company in the U.S. with a license to the proprietary technology for harvesting and expanding two types of cells from cord lining.
Browse the newly designed website at www.stemcyte.com
The StemCyte Difference
Located in the United States, India and Taiwan, StemCyte specializes in both private banking and public collection of cord blood. They have established one of the largest, most racially diverse and highest quality cord blood stem cell banks in the world. Through its unique LifeSaver Guarantee, parents can be confident their baby's cord blood is backed by one of the world's largest and most diversified inventories of cord blood units donated for public use.
StemCyte has an exceptional track record of providing cord blood units for transplants in children and adults. They have supplied units for nearly 2,000 life-saving transplants - and counting! Due to the company's commitment to higher standards in collection and processing, units from StemCyte are strongly preferred by leading transplant centers worldwide. Moreover, StemCyte is one of the only for-profit companies contracted by the U.S. Department of HHS to help contribute clinical grade cord blood units to the public National Cord Blood Inventory for unrelated transplants. Learn more at stemcyte.com.
For media inquiries, contact Wendy Roberts, Public Relations Director at Orca Communications LLC, at email@example.com or (480) 346-4004.
Media Contact: Wendy Roberts, Orca Communications Unlimited LLC, (480) 346-4004, firstname.lastname@example.org
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE StemCyte, Inc.